miRNA World 2014 will provide the industry’s definitive platform maximizing the clinical potential of miRNAs. By bringing together the academic, pharmaceutical and biotechnology leaders who are leading this dynamic area of research, miRNA World 2014 will be discussing the biggest challenges and opportunities currently within the miRNA field.
miRNA World 2014 will enable you to maximize the therapeutic potential of miRNAs by discovering the latest and greatest advancements in therapeutic delivery, pharmacology strategy and target validation.
Optimize your pre-clinical research with miRNAs to advance your understanding of everything from basic biogenesis to how to transition into the clinic. Realize the diagnostic application of circulating, exosomal and cellular miRNAs as non-invasive markers for disease.
Utilizing a multitude of interactive formats, such as keynote interviews, panel discussions, roundtables and interactive solution finding sessions, miRNA World 2014 will provide you with the answers to all of your miRNA questions.
Network with the experts and those who feel confined by the same challenges as you to:
- Overcome the miRNA therapeutic delivery bottleneck to effectively transport miRNA anti-miRs and mimics to your desired target site
- Amplify your diagnostic arsenal through identification of circulating, exosomal and cellular miRNAs for prognosis and diagnosis of complex and specific diseases
- Blueprint your pharmacology strategy for miRNA therapeutics to maximize efficacy and negate off-target effects
- Validate clinical biomarkers and target identification to maximize output from pre-clinical and clinical research
- Understand and apply novel approaches and opportunities such 3’ UTR polymorphisms, normalization strategies and how fundamental understanding of basic miRNA biology impacts clinical research and development
- miRNA World 2014 is bringing together the large, medium and small pharma who are all realizing the therapeutic potential of miRNAs as both drug targets and drugs themselves.
- The industry is rapidly overcoming the key barriers for miRNA therapeutics, such as delivery and off-target effects and miRNA World 2014 is bringing together those who are at the forefront of these issues.
- miRNAs are showing real clinical significance as biomarkers and we have brought together those who are leading the way with circulating, exosomal and cellular miRNAs as biomarkers.
- Partnerships between pharma, academia and biotech are crucial in this industry and miRNA World 2014 provides an abundance of networking and interactive sessions to cultivate partnerships and connections.
- miRNA World 2014 also focuses on more emerging opportunities such as miRNA-based diagnostics, data normalization and how our gaps in the understanding of basic miRNA biogenesis impact on therapeutic potential.